BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15964643)

  • 1. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
    Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
    Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
    J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
    Mazza A; Bendini MG; Cristofori M; Nardi S; Leggio M; De Cristofaro R; Giordano A; Cozzari L; Giordano G; Cappato R
    Europace; 2009 Jul; 11(7):902-9. PubMed ID: 19443431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
    Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
    Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
    Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone.
    Kapoor A; Kumar S; Singh RK; Pandey CM; Sinha N
    J Heart Valve Dis; 2002 Nov; 11(6):802-9. PubMed ID: 12479281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.
    Ozaydin M; Varol E; Aslan SM; Kucuktepe Z; Dogan A; Ozturk M; Altinbas A
    Am J Cardiol; 2006 May; 97(10):1490-3. PubMed ID: 16679090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation.
    Lin YJ; Tsao HM; Chang SL; Lo LW; Tuan TC; Hu YF; Udyavar AR; Tsai WC; Chang CJ; Tai CT; Lee PC; Suenari K; Huang SY; Nguyen HT; Chen SA
    Am J Cardiol; 2010 Feb; 105(4):495-501. PubMed ID: 20152244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion.
    Ferro D; Franciosa P; Cangemi R; Carnevale R; Pignatelli P; Loffredo L; Perri L; Catasca E; Violi F
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):327-33. PubMed ID: 22362890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.